Missing/wrong data?
Log in to edit
Outcomes from second-line therapy in long-term responders to first-line tyrosine kinase inhibitor in clear-cell metastatic renal cell carcinoma.
scientific article published on December 2014
Author/s
author: Camillo Porta, Benoit Beuselinck, Yann Alexandre Vano, Philip R. Debruyne, Alain Ravaud, Grégoire Marret
Work details
Publication date
December 1, 2014
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.